1Kumagai K, Nakashima H, Saku K. The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cadiovase Rcs ,2004,62 : 105-111.
2Marin F, Pascual DA, Roldan V, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol in press.
3Young-Xu Y, Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol,2003,92 : 1379-1383.
4Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol,2003,92 : 1343-1345.
6Shiroshita-Takeshita A, Schram G, Lavoie J, et al. Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs. Circulation,2004,110:2313-2319.
8Fonarow GC, Wright RS, Spencer FA, ct al. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol,2005 ,96 :611-616.
9Chiu JH, Abdelhadi RH, Chung MK, et al. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator. Am J Cardiol,2005,95:490-491.
10Mitchell LB, Powell JL,Gillis AM,et al. Are lipid-lowing drugs also antiarrhvthmic drugs? J Am Coll Cardiol,2003,42 :81-87.
二级参考文献24
1Frustaci A,Chimenti C,Bellocci F,et al.Histological substrate of atrial biopsies in patients with lone atrial fibrillation.Circulation,1997,96:1180-1184.
2Aviles RJ,Martin DO,Hassen CA,et al.Inflammation as a risk factor for atrial fibrillation.Circulation,2003,108:3006-3010.
3Scalia R,Gooszen ME,Jones SP,et al.Simvastatin exerts both anti-imflammatory and cardioprotective.Effects in apolipoprotein E-deficient mice.Circulation,2001,103:2598-2603.
4van de Ree MA,Huisman MV,Princen HMG,et al.Strong decrease of high sensitivity C-reactive protein with high-dose atovastatin in patients with type 2 diabetes mellitus.Atherosclerosis,2003,166:129-135.
5Li D,Fareh S,Leung TK,et al.Promotion of atrial fibrillation by heart failure in dog:atrial remodeling of a different sort.Circulation,1999,100:87-95.
6Mihm MJ,Yu F,Cames CA,et al.Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation.Circulation,2001,104:174-180.
7Chung MK,Martin DO,Sprecher D,et al.C-reactive protein elevation in patients with atrial arrhythmias.Circulation,2001,104:2886-2891.
8Lefer AM,Campbell B,Shin YK,et al.Simvastatin preserves the ischemic-reperfused myocardium in normocholerterolemic rat hearts.Circulation,1999,100:178-184.
9Xu YY,Jabbour S,Goldberg k,et al.Usefulness of station drugs in protecting against atrial fibrillation in patients with CorOnary artery disease.Am J Cardiol,2003,92:1379-1383.
10Mark L,Katona A.Effect of fluvastatin on QT dispersion:a new pleiotropic effect? Am J Cardiol,2000;85(7):919-920
